FindTrial
Sign In

The Role of tNGS in Diagnosing and Treating Infectious Complications after Pancreaticoduodenectomy

The Role of tNGS in Diagnosing and Treating Infectious Complications after Pancreaticoduodenectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092442
Enrollment
Unknown
Registered
2024-11-15
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative infectious complications after pancreatoduodenectomy

Interventions

Gold Standard:conventional microbial culture
Index test:tNGS

Sponsors

Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.>18  years of age; 2.indicated for elective pancreatoduodenectomy (PD); 3.the patient and their family or legal guardian voluntarily agree to and sign the informed consent form; 4.the patient demonstrates good compliance and can adhere to the prescribed medication regimen;

Exclusion criteria

Exclusion criteria: 1.unable to tolerate pancreatoduodenectomy (PD) due to cardiac and pulmonary function limitations; 2.pregnant and breastfeeding women; 3.individuals unwilling to participate in this study;

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Detecting consistency;Predicted abundance of pathogenic bacteria;—

Countries

China

Contacts

Public ContactXu Fu

Drum Tower Hospital

fuxunju2012@163.com+86 18205188516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026